 |
docosahexanoic acid-paclitaxel |
|---|---|
| Trade Name | Taxoprexin |
| Orphan Indication | Hormone-refractory prostate cancer |
| USA Market Approval | USA |
| USA Designation Date | 2001-03-05 00:00:00 |
| Sponsor | Luitpold Pharmaceuticals, Inc.;One Luitpold Drive;Shirley, New York, 11976 |
